Mechanistic aspects of crosstalk between GH and PRL and ErbB receptor family signaling

Journal of Mammary Gland Biology and Neoplasia

Volumn 13, Issue 1, 2008, Pages 119-129

  Frank, Stuart J ^a,b  

^a University of Alabama at Birmingham   (United States)

^b BIRMINGHAM VA MEDICAL CENTER   (United States)

Author keywords

EGF; ErbB receptor; GH receptor; PRL receptor

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; GROWTH HORMONE RECEPTOR; MONOCLONAL ANTIBODY; PROLACTIN; PROLACTIN RECEPTOR; PROTEIN SERINE THREONINE KINASE; PROTEIN TYROSINE KINASE INHIBITOR;

BREAST CANCER; BREAST CARCINOGENESIS; BREAST DEVELOPMENT; CANCER CELL; CANCER GROWTH; DRUG RESEARCH; GENE MUTATION; GENE OVEREXPRESSION; HORMONE ACTION; HUMAN; METASTASIS POTENTIAL; MUTATIONAL ANALYSIS; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN DEPHOSPHORYLATION; PROTEIN DETERMINATION; PROTEIN DOMAIN; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; RECEPTOR BINDING; RECEPTOR DOWN REGULATION; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

EID: 40249094410     PISSN: 10833021     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10911-008-9065-9     Document Type: Review

References (136)

1. 1. DF Stern 2003 ErbBs in mammary development Exp Cell Res. 284 1 89 98 12648468 1:CAS:528:DC%2BD3sXitVylt7w%3D Stern DF. ErbBs in mammary development. Exp Cell Res. 2003;284(1):89–98.
2. 2. KL Troyer DC Lee 2001 Regulation of mouse mammary gland development and tumorigenesis by the ERBB signaling network J Mammary Gland Biol Neoplasia. 6 1 7 21 11467454 1:STN:280:DC%2BD38%2FitlOksQ%3D%3D Troyer KL, Lee DC. Regulation of mouse mammary gland development and tumorigenesis by the ERBB signaling network. J Mammary Gland Biol Neoplasia. 2001;6(1):7–21.
3. 3. MA Olayioye RM Neve HA Lane NE Hynes 2000 The ErbB signaling network: receptor heterodimerization in development and cancer EMBO J. 19 13 3159 3167 10880430 1:CAS:528:DC%2BD3cXlt1ajtLY%3D Olayioye MA, Neve RM, Lane HA, Hynes NE. The ErbB signaling network: receptor heterodimerization in development and cancer. EMBO J. 2000;19(13):3159–67.
4. 4. Y Yarden MX Sliwkowski 2001 Untangling the ErbB signalling network Nat Rev Mol Cell Biol 2 2 127 137 11252954 1:CAS:528:DC%2BD3MXivVWnt7k%3D Yarden Y, Sliwkowski MX. Untangling the ErbB signalling network. Nat Rev Mol Cell Biol 2001;2(2):127–37.
5. 5. J Boonstra P Rijken B Humbel F Cremers A Verkleij P Bergen en Henegouwen van 1995 The epidermal growth factor Cell Biol Int. 19 5 413 430 7640657 1:CAS:528:DyaK2MXnsVeltLg%3D Boonstra J, Rijken P, Humbel B, Cremers F, Verkleij A, van Bergen en Henegouwen P. The epidermal growth factor. Cell Biol Int. 1995;19(5):413–30.
6. 6. CR Lin WS Chen W Kruiger LS Stolarsky W Weber RM Evans 1984 Expression cloning of human EGF receptor complementary DNA: gene amplification and three related messenger RNA products in A431 cells Science. 224 4651 843 848 6326261 1:CAS:528:DyaL2cXksV2ms7w%3D Lin CR, Chen WS, Kruiger W, Stolarsky LS, Weber W, Evans RM, et al. Expression cloning of human EGF receptor complementary DNA: gene amplification and three related messenger RNA products in A431 cells. Science. 1984;224(4651):843–8.
7. 7. CI Bargmann MC Hung RA Weinberg 1986 The neu oncogene encodes an epidermal growth factor receptor-related protein Nature. 319 6050 226 230 3945311 1:CAS:528:DyaL28XhtVensLk%3D Bargmann CI, Hung MC, Weinberg RA. The neu oncogene encodes an epidermal growth factor receptor-related protein. Nature. 1986;319(6050):226–30.
8. 8. MH Kraus W Issing T Miki NC Popescu SA Aaronson 1989 Isolation and characterization of ERBB3, a third member of the ERBB/epidermal growth factor receptor family: evidence for overexpression in a subset of human mammary tumors Proc Natl Acad Sci U S A. 86 23 9193 9197 2687875 1:CAS:528:DyaK3cXhtlenu7Y%3D Kraus MH, Issing W, Miki T, Popescu NC, Aaronson SA. Isolation and characterization of ERBB3, a third member of the ERBB/epidermal growth factor receptor family: evidence for overexpression in a subset of human mammary tumors. Proc Natl Acad Sci U S A. 1989;86(23):9193–7.
9. 9. GD Plowman JM Green JM Culouscou GW Carlton VM Rothwell S Buckley 1993 Heregulin induces tyrosine phosphorylation of HER4/p180erbB4 Nature 366 6454 473 475 7902537 1:CAS:528:DyaK2cXhtVaru7w%3D Plowman GD, Green JM, Culouscou JM, Carlton GW, Rothwell VM, Buckley S. Heregulin induces tyrosine phosphorylation of HER4/p180erbB4. Nature 1993;366(6454):473–5.
10. 10. D Karunagaran E Tzahar RR Beerli X Chen D Graus-Porta BJ Ratzkin 1996 ErbB-2 is a common auxiliary subunit of NDF and EGF receptors: implications for breast cancer EMBO J 15 2 254 264 8617201 1:CAS:528:DyaK28XovFSksQ%3D%3D Karunagaran D, Tzahar E, Beerli RR, Chen X, Graus-Porta D, Ratzkin BJ, et al. ErbB-2 is a common auxiliary subunit of NDF and EGF receptors: implications for breast cancer. EMBO J 1996;15(2):254–64.
11. 11. D Graus-Porta RR Beerli JM Daly NE Hynes 1997 ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling EMBO J 16 7 1647 1655 9130710 1:CAS:528:DyaK2sXislKltLo%3D Graus-Porta D, Beerli RR, Daly JM, Hynes NE. ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling. EMBO J 1997;16(7):1647–55.
12. 12. B Linggi G Carpenter 2006 ErbB receptors: new insights on mechanisms and biology Trends Cell Biol. 16 12 649 656 17085050 1:CAS:528:DC%2BD28Xht1OhtLnM Linggi B, Carpenter G. ErbB receptors: new insights on mechanisms and biology. Trends Cell Biol. 2006;16(12):649–56.
13. 13. SL Wu J Kim RW Bandle L Liotta E Petricoin BL Karger 2006 Dynamic profiling of the post-translational modifications and interaction partners of epidermal growth factor receptor signaling after stimulation by epidermal growth factor using extended range proteomic analysis (ERPA) Mol Cell Proteomics 5 9 1610 1627 16799092 1:CAS:528:DC%2BD28XpvVGgurY%3D Wu SL, Kim J, Bandle RW, Liotta L, Petricoin E, Karger BL. Dynamic profiling of the post-translational modifications and interaction partners of epidermal growth factor receptor signaling after stimulation by epidermal growth factor using extended range proteomic analysis (ERPA). Mol Cell Proteomics 2006;5(9):1610–27.
14. 14. E Boeri Erba E Bergatto S Cabodi L Silengo G Tarone P Defilippi 2005 Systematic analysis of the epidermal growth factor receptor by mass spectrometry reveals stimulation-dependent multisite phosphorylation Mol Cell Proteomics. 4 8 1107 1121 15901825 Boeri Erba E, Bergatto E, Cabodi S, Silengo L, Tarone G, Defilippi P, et al. Systematic analysis of the epidermal growth factor receptor by mass spectrometry reveals stimulation-dependent multisite phosphorylation. Mol Cell Proteomics. 2005;4(8):1107–21.
15. 15. L Guo CJ Kozlosky LH Ericsson TO Daniel DP Cerretti RS Johnson 2003 Studies of ligand-induced site-specific phosphorylation of epidermal growth factor receptor J Am Soc Mass Spectrom. 14 9 1022 1031 12954170 1:CAS:528:DC%2BD3sXmvV2rsLs%3D Guo L, Kozlosky CJ, Ericsson LH, Daniel TO, Cerretti DP, Johnson RS. Studies of ligand-induced site-specific phosphorylation of epidermal growth factor receptor. J Am Soc Mass Spectrom. 2003;14(9):1022–31.
16. 16. WX Schulze L Deng M Mann 2005 Phosphotyrosine interactome of the ErbB-receptor kinase family Mol Syst Biol. 1 2005.0008 16729043 Schulze WX, Deng L, Mann M. Phosphotyrosine interactome of the ErbB-receptor kinase family. Mol Syst Biol. 2005;1:2005.0008.
17. 17. RN Jorissen F Walker N Pouliot TP Garrett CW Ward AW Burgess 2003 Epidermal growth factor receptor: mechanisms of activation and signalling Exp Cell Res. 284 1 31 53 12648464 1:CAS:528:DC%2BD3sXitVyltr0%3D Jorissen RN, Walker F, Pouliot N, Garrett TP, Ward CW, Burgess AW. Epidermal growth factor receptor: mechanisms of activation and signalling. Exp Cell Res. 2003;284(1):31–53.
18. 18. HS Wiley SY Shvartsman DA Lauffenburger 2003 Computational modeling of the EGF-receptor system: a paradigm for systems biology Trends Cell Biol. 13 1 43 50 12480339 1:CAS:528:DC%2BD38XptlWjtb4%3D Wiley HS, Shvartsman SY, Lauffenburger DA. Computational modeling of the EGF-receptor system: a paradigm for systems biology. Trends Cell Biol. 2003;13(1):43–50.
19. 19. DJ Katzmann G Odorizzi SD Emr 2002 Receptor downregulation and multivesicular-body sorting Nat Rev Mol Cell Biol. 3 12 893 905 12461556 1:CAS:528:DC%2BD38XptFKnt7s%3D Katzmann DJ, Odorizzi G, Emr SD. Receptor downregulation and multivesicular-body sorting. Nat Rev Mol Cell Biol. 2002;3(12):893–905.
20. 20. SJ Kil C Carlin 2000 EGF receptor residues leu(679), leu(680) mediate selective sorting of ligand-receptor complexes in early endosomal compartments J Cell Physiol. 185 1 47 60 10942518 1:CAS:528:DC%2BD3cXmt1Ors74%3D Kil SJ, Carlin C. EGF receptor residues leu(679), leu(680) mediate selective sorting of ligand-receptor complexes in early endosomal compartments. J Cell Physiol. 2000;185(1):47–60.
21. 21. S Felder K Miller G Moehren A Ullrich J Schlessinger CR Hopkins 1990 Kinase activity controls the sorting of the epidermal growth factor receptor within the multivesicular body Cell 61 4 623 634 2344614 1:CAS:528:DyaK3cXktlGgt7g%3D Felder S, Miller K, Moehren G, Ullrich A, Schlessinger J, Hopkins CR. Kinase activity controls the sorting of the epidermal growth factor receptor within the multivesicular body. Cell 1990;61(4):623–34.
22. 22. CA Joazeiro SS Wing H Huang JD Leverson T Hunter YC Liu 1999 The tyrosine kinase negative regulator c-Cbl as a RING-type, E2-dependent ubiquitin-protein ligase Science. 286 5438 309 312 10514377 1:CAS:528:DyaK1MXmvVCgu70%3D Joazeiro CA, Wing SS, Huang H, Leverson JD, Hunter T, Liu YC. The tyrosine kinase negative regulator c-Cbl as a RING-type, E2-dependent ubiquitin-protein ligase. Science. 1999;286(5438):309–12.
23. 23. H Waterman G Levkowitz I Alroy Y Yarden 1999 The RING finger of c-Cbl mediates desensitization of the epidermal growth factor receptor J Biol Chem. 274 32 22151 22154 10428778 1:CAS:528:DyaK1MXlt1Cgtbo%3D Waterman H, Levkowitz G, Alroy I, Yarden Y. The RING finger of c-Cbl mediates desensitization of the epidermal growth factor receptor. J Biol Chem. 1999;274(32):22151–4.
24. 24. G Levkowitz H Waterman E Zamir Z Kam S Oved WY Langdon 1998 c-Cbl/Sli-1 regulates endocytic sorting and ubiquitination of the epidermal growth factor receptor Genes Dev. 12 23 3663 3674 9851973 1:CAS:528:DyaK1MXhtVantA%3D%3D Levkowitz G, Waterman H, Zamir E, Kam Z, Oved S, Langdon WY, et al. c-Cbl/Sli-1 regulates endocytic sorting and ubiquitination of the epidermal growth factor receptor. Genes Dev. 1998;12(23):3663–74.
25. 25. A Wells JB Welsh CS Lazar HS Wiley GN Gill MG Rosenfeld 1990 Ligand-induced transformation by a noninternalizing epidermal growth factor receptor Science. 247 4945 962 964 2305263 1:CAS:528:DyaK3cXhslaqurw%3D Wells A, Welsh JB, Lazar CS, Wiley HS, Gill GN, Rosenfeld MG. Ligand-induced transformation by a noninternalizing epidermal growth factor receptor. Science. 1990;247(4945):962–4.
26. 26. BP Ceresa SL Schmid 2000 Regulation of signal transduction by endocytosis Curr Opin Cell Biol. 12 2 204 210 10712919 1:CAS:528:DC%2BD3cXitVantLc%3D Ceresa BP, Schmid SL. Regulation of signal transduction by endocytosis. Curr Opin Cell Biol. 2000;12(2):204–10.
27. 27. PP Fiore Di P Camilli De 2001 Endocytosis and signaling: an inseparable partnership Cell. 106 1 1 4 11461694 Di Fiore PP, De Camilli P. Endocytosis and signaling: an inseparable partnership. Cell. 2001;106(1):1–4.
28. 28. P Burke K Schooler HS Wiley 2001 Regulation of epidermal growth factor receptor signaling by endocytosis and intracellular trafficking Mol Biol Cell. 12 6 1897 1910 11408594 1:CAS:528:DC%2BD3MXotVSjtrc%3D Burke P, Schooler K, Wiley HS. Regulation of epidermal growth factor receptor signaling by endocytosis and intracellular trafficking. Mol Biol Cell. 2001;12(6):1897–910.
29. 29. A Pol M Calvo C Enrich 1998 Isolated endosomes from quiescent rat liver contain the signal transduction machinery. Differential distribution of activated Raf-1 and Mek in the endocytic compartment FEBS Lett. 441 1 34 38 9877160 1:CAS:528:DyaK1cXotVKjs74%3D Pol A, Calvo M, Enrich C. Isolated endosomes from quiescent rat liver contain the signal transduction machinery. Differential distribution of activated Raf-1 and Mek in the endocytic compartment. FEBS Lett. 1998;441(1):34–8.
30. 30. GM Guglielmo Di PC Baass WJ Ou BI Posner JJ Bergeron 1994 Compartmentalization of SHC, GRB2 and mSOS, and hyperphosphorylation of Raf-1 by EGF but not insulin in liver parenchyma EMBO J. 13 18 4269 4277 7925272 Di Guglielmo GM, Baass PC, Ou WJ, Posner BI, Bergeron JJ. Compartmentalization of SHC, GRB2 and mSOS, and hyperphosphorylation of Raf-1 by EGF but not insulin in liver parenchyma. EMBO J. 1994;13(18):4269–77.
31. 31. MP Oksvold E Skarpen B Lindeman N Roos HS Huitfeldt 2000 Immunocytochemical localization of Shc and activated EGF receptor in early endosomes after EGF stimulation of HeLa cells J Histochem Cytochem. 48 1 21 33 10653583 1:CAS:528:DC%2BD3cXntFCrug%3D%3D Oksvold MP, Skarpen E, Lindeman B, Roos N, Huitfeldt HS. Immunocytochemical localization of Shc and activated EGF receptor in early endosomes after EGF stimulation of HeLa cells. J Histochem Cytochem. 2000;48(1):21–33.
32. 32. MS Berger GW Locher S Saurer WJ Gullick MD Waterfield B Groner 1988 Correlation of c-erbB-2 gene amplification and protein expression in human breast carcinoma with nodal status and nuclear grading Cancer Res. 48 5 1238 1243 2893663 1:CAS:528:DyaL1cXhsVyjtbs%3D Berger MS, Locher GW, Saurer S, Gullick WJ, Waterfield MD, Groner B, et al. Correlation of c-erbB-2 gene amplification and protein expression in human breast carcinoma with nodal status and nuclear grading. Cancer Res. 1988;48(5):1238–43.
33. 33. W Xie AJ Paterson E Chin LM Nabell JE Kudlow 1997 Targeted expression of a dominant negative epidermal growth factor receptor in the mammary gland of transgenic mice inhibits pubertal mammary duct development Mol Endocrinol. 11 12 1766 1781 9369445 1:CAS:528:DyaK2sXmvFOrt70%3D Xie W, Paterson AJ, Chin E, Nabell LM, Kudlow JE. Targeted expression of a dominant negative epidermal growth factor receptor in the mammary gland of transgenic mice inhibits pubertal mammary duct development. Mol Endocrinol. 1997;11(12):1766–81.
34. 34. DF Stern 2000 Tyrosine kinase signalling in breast cancer: ErbB family receptor tyrosine kinases Breast Cancer Res. 2 3 176 183 11250707 1:CAS:528:DC%2BD3cXls1Smurs%3D Stern DF. Tyrosine kinase signalling in breast cancer: ErbB family receptor tyrosine kinases. Breast Cancer Res. 2000;2(3):176–83.
35. 35. JS Biscardi RC Ishizawar CM Silva SJ Parsons 2000 Tyrosine kinase signalling in breast cancer: epidermal growth factor receptor and c-Src interactions in breast cancer Breast Cancer Res. 2 3 203 210 11250711 1:CAS:528:DC%2BD3cXls1Sltb0%3D Biscardi JS, Ishizawar RC, Silva CM, Parsons SJ. Tyrosine kinase signalling in breast cancer: epidermal growth factor receptor and c-Src interactions in breast cancer. Breast Cancer Res. 2000;2(3):203–10.
36. 36. J Mendelsohn J Baselga 2000 The EGF receptor family as targets for cancer therapy Oncogene 19 56 6550 6565 11426640 1:CAS:528:DC%2BD3MXhsF2ku7k%3D Mendelsohn J, Baselga J. The EGF receptor family as targets for cancer therapy. Oncogene 2000;19(56):6550–65.
37. 37. J Mendelsohn J Baselga 2003 Status of epidermal growth factor receptor antagonists in the biology and treatment of cancer J Clin Oncol. 21 14 2787 2799 12860957 1:CAS:528:DC%2BD2cXptlCktbo%3D Mendelsohn J, Baselga J. Status of epidermal growth factor receptor antagonists in the biology and treatment of cancer. J Clin Oncol. 2003;21(14):2787–99.
38. 38. EM Bublil Y Yarden 2007 The EGF receptor family: spearheading a merger of signaling and therapeutics Curr Opin Cell Biol. 19 2 124 134 17314037 1:CAS:528:DC%2BD2sXjt1Slu7w%3D Bublil EM, Yarden Y. The EGF receptor family: spearheading a merger of signaling and therapeutics. Curr Opin Cell Biol. 2007;19(2):124–34.
39. 39. DJ Riese 2nd RM Gallo J Settleman 2007 Mutational activation of ErbB family receptor tyrosine kinases: insights into mechanisms of signal transduction and tumorigenesis Bioessays. 29 6 558 565 17508401 1:CAS:528:DC%2BD2sXntVCmuro%3D Riese DJ 2nd, Gallo RM, Settleman J. Mutational activation of ErbB family receptor tyrosine kinases: insights into mechanisms of signal transduction and tumorigenesis. Bioessays. 2007;29(6):558–65.
40. 40. AJ Jackson-Fisher G Bellinger R Ramabhadran JK Morris KF Lee DF Stern 2004 ErbB2 is required for ductal morphogenesis of the mammary gland Proc Natl Acad Sci U S A. 101 49 17138 17143 15569931 1:CAS:528:DC%2BD2cXhtFagu7bI Jackson-Fisher AJ, Bellinger G, Ramabhadran R, Morris JK, Lee KF, Stern DF. ErbB2 is required for ductal morphogenesis of the mammary gland. Proc Natl Acad Sci U S A. 2004;101(49):17138–43.
41. 41. SP Ethier 1995 Growth factor synthesis and human breast cancer progression J Natl Cancer Inst. 87 13 964 973 7629883 1:CAS:528:DyaK2MXnsVemu78%3D Ethier SP. Growth factor synthesis and human breast cancer progression. J Natl Cancer Inst. 1995;87(13):964–73.
42. 42. RC Humphreys L Hennighausen 2000 Transforming growth factor alpha and mouse models of human breast cancer Oncogene. 19 8 1085 1091 10713694 1:CAS:528:DC%2BD3cXitVegsrg%3D Humphreys RC, Hennighausen L. Transforming growth factor alpha and mouse models of human breast cancer. Oncogene. 2000;19(8):1085–91.
43. 43. C Morris 2002 The role of EGFR-directed therapy in the treatment of breast cancer Breast Cancer Res Treat. 75 1 S51 55 12353824 1:CAS:528:DC%2BD38Xms1ersbc%3D Morris C. The role of EGFR-directed therapy in the treatment of breast cancer. Breast Cancer Res Treat. 2002;75(1):S51–55.
44. 44. OG Isaksson S Eden JO Jansson 1985 Mode of action of pituitary growth hormone on target cells Annu Rev Physiol. 47 1 483 499 3888078 1:CAS:528:DyaL2MXktVSltL0%3D Isaksson OG, Eden S, Jansson JO. Mode of action of pituitary growth hormone on target cells. Annu Rev Physiol. 1985;47(1):483–99.
45. 45. S Kaplan 1999 Chapter 5: Hormonal regulation of growth and metabolic effects of growth hormone JLG Kostyo Handbook of Physiology Oxford University Press New York 129 143 Kaplan S. Chapter 5: Hormonal regulation of growth and metabolic effects of growth hormone. In: Kostyo JLG, editor. Handbook of Physiology. New York: Oxford University Press; 1999. p. 129–43.
46. 46. SJ Frank JL Messina 2002 Growth Hormone Receptor JJ Oppenheim M Feldman Cytokine Reference On-Line Academic Press, Harcourt London, UK 1 21 Frank SJ, Messina JL. Growth Hormone Receptor. In: Oppenheim JJ, Feldman M, editors. Cytokine Reference On-Line. London, UK: Academic Press, Harcourt; 2002. p. 1–21.
47. 47. C Carter Su J Schwartz LS Smit 1996 Molecular mechanism of growth hormone action Annu Rev Physiol. 58 187 207 8815791 1:CAS:528:DyaK28XhvVahsbs%3D Carter Su C, Schwartz J, Smit LS. Molecular mechanism of growth hormone action. Annu Rev Physiol. 1996;58:187–207.
48. 48. Frank SJ, O’Shea JJ, editors. Recent advances in cytokine signal transduction: lessons from growth hormone and other cytokines. Greenwich, CT; 1999.
49. 49. DW Leung SA Spencer G Cachianes RG Hammonds C Collins WJ Henzel 1987 Growth hormone receptor and serum binding protein: purification, cloning and expression Nature 330 537 543 2825030 1:CAS:528:DyaL1cXjtlyjuw%3D%3D Leung DW, Spencer SA, Cachianes G, Hammonds RG, Collins C, Henzel WJ, et al. Growth hormone receptor and serum binding protein: purification, cloning and expression. Nature 1987;330:537–43.
50. 50. JF Bazan 1990 Structural design and molecular evolution of a cytokine receptor superfamily Proc Natl Acad Sci U S A. 87 18 6934 6938 2169613 1:CAS:528:DyaK3cXlvV2nurc%3D Bazan JF. Structural design and molecular evolution of a cytokine receptor superfamily. Proc Natl Acad Sci U S A. 1990;87(18):6934–8.
51. 51. AM Vos de M Ultsch AA Kossiakoff 1992 Human growth hormone and extracellular domain of its receptor: crystal structure of the complex Science 255 5042 306 312 1549776 de Vos AM, Ultsch M, Kossiakoff AA. Human growth hormone and extracellular domain of its receptor: crystal structure of the complex. Science 1992;255(5042):306–12.
52. 52. BC Cunningham M Ultsch AM Vos De MG Mulkerrin KR Clauser JA Wells 1991 Dimerization of the extracellular domain of the human growth hormone receptor by a single hormone molecule Science. 254 5033 821 825 1948064 1:CAS:528:DyaK38XotFE%3D Cunningham BC, Ultsch M, De Vos AM, Mulkerrin MG, Clauser KR, Wells JA. Dimerization of the extracellular domain of the human growth hormone receptor by a single hormone molecule. Science. 1991;254(5033):821–5.
53. 53. G Fuh BC Cunningham R Fukunaga S Nagata DV Goeddel JA Wells 1992 Rational design of potent antagonists to the human growth hormone receptor Science. 256 5064 1677 1680 1535167 1:CAS:528:DyaK38Xks1egt7w%3D Fuh G, Cunningham BC, Fukunaga R, Nagata S, Goeddel DV, Wells JA. Rational design of potent antagonists to the human growth hormone receptor. Science. 1992;256(5064):1677–80.
54. 54. J Gent P Kerkhof van M Roza G Bu GJ Strous 2002 Ligand-independent growth hormone receptor dimerization occurs in the endoplasmic reticulum and is required for ubiquitin system-dependent endocytosis Proc Natl Acad Sci U S A. 99 15 9858 9863 12105275 1:CAS:528:DC%2BD38XlslKgsLs%3D Gent J, van Kerkhof P, Roza M, Bu G, Strous GJ. Ligand-independent growth hormone receptor dimerization occurs in the endoplasmic reticulum and is required for ubiquitin system-dependent endocytosis. Proc Natl Acad Sci U S A. 2002;99(15):9858–63.
55. 55. SJ Frank 2002 Receptor dimerization in GH and erythropoietin action—it takes two to tango, but how? Endocrinology. 143 1 2 10 11751584 1:CAS:528:DC%2BD38XjtVOksA%3D%3D Frank SJ. Receptor dimerization in GH and erythropoietin action—it takes two to tango, but how? Endocrinology. 2002;143(1):2–10.
56. 56. Y Zhang J Jiang JJ Kopchick SJ Frank 1999 Disulfide linkage of growth hormone (GH) receptors (GHR) reflects GH-induced GHR dimerization. Association of JAK2 with the GHR is enhanced by receptor dimerization J Biol Chem. 274 46 33072 33084 10551877 1:CAS:528:DyaK1MXntlygu7s%3D Zhang Y, Jiang J, Kopchick JJ, Frank SJ. Disulfide linkage of growth hormone (GH) receptors (GHR) reflects GH-induced GHR dimerization. Association of JAK2 with the GHR is enhanced by receptor dimerization. J Biol Chem. 1999;274(46):33072–84.
57. 57. LS Argetsinger GS Campbell X Yang BA Witthuhn O Silvennoinen JN Ihle 1993 Identification of JAK2 as a growth hormone receptor-associated tyrosine kinase Cell. 74 2 237 244 8343952 1:CAS:528:DyaK3sXmtFOkt7c%3D Argetsinger LS, Campbell GS, Yang X, Witthuhn BA, Silvennoinen O, Ihle JN, et al. Identification of JAK2 as a growth hormone receptor-associated tyrosine kinase. Cell. 1993;74(2):237–44.
58. 58. O Silvennoinen BA Witthuhn FW Quelle JL Cleveland T Yi JN Ihle 1993 Structure of the murine Jak2 protein-tyrosine kinase and its role in interleukin 3 signal transduction Proc Natl Acad Sci U S A. 90 8429 8433 8378315 1:CAS:528:DyaK2cXivFSmsQ%3D%3D Silvennoinen O, Witthuhn BA, Quelle FW, Cleveland JL, Yi T, Ihle JN. Structure of the murine Jak2 protein-tyrosine kinase and its role in interleukin 3 signal transduction. Proc Natl Acad Sci U S A. 1993;90:8429–33.
59. 59. SJ Frank G Gilliland AS Kraft CS Arnold 1994 Interaction of the growth hormone receptor cytoplasmic domain with the JAK2 tyrosine kinase Endocrinology. 135 5 2228 2239 7956946 1:CAS:528:DyaK2MXitV2jsb4%3D Frank SJ, Gilliland G, Kraft AS, Arnold CS. Interaction of the growth hormone receptor cytoplasmic domain with the JAK2 tyrosine kinase. Endocrinology. 1994;135(5):2228–39.
60. 60. A Sotiropoulos M Perrot-Applanat H Dinerstein A Pallier MC Postel-Vinay J Finidori 1994 Distinct cytoplasmic regions of the growth hormone receptor are required for activation of JAK2, mitogen-activated protein kinase, and transcription Endocrinology. 135 4 1292 1298 7925092 1:CAS:528:DyaK2cXmt1aht70%3D Sotiropoulos A, Perrot-Applanat M, Dinerstein H, Pallier A, Postel-Vinay MC, Finidori J, et al. Distinct cytoplasmic regions of the growth hormone receptor are required for activation of JAK2, mitogen-activated protein kinase, and transcription. Endocrinology. 1994;135(4):1292–8.
61. 61. JA Vanderkuur X Wang L Zhang GS Campbell G Allevato N Billestrup 1994 Domains of the growth hormone receptor required for association and activation of JAK2 tyrosine kinase J Biol Chem. 269 21709 21717 8063815 1:CAS:528:DyaK2cXlsV2hurk%3D Vanderkuur JA, Wang X, Zhang L, Campbell GS, Allevato G, Billestrup N, et al. Domains of the growth hormone receptor required for association and activation of JAK2 tyrosine kinase. J Biol Chem. 1994;269:21709–17.
62. 62. SJ Frank W Yi Y Zhao JF Goldsmith G Gilliland J Jiang 1995 Regions of the JAK2 tyrosine kinase required for coupling to the growth hormone receptor J Biol Chem 270 24 14776 14785 7540178 1:CAS:528:DyaK2MXmsVSiu7Y%3D Frank SJ, Yi W, Zhao Y, Goldsmith JF, Gilliland G, Jiang J, et al. Regions of the JAK2 tyrosine kinase required for coupling to the growth hormone receptor. J Biol Chem 1995;270(24):14776–85.
63. 63. JW Tanner W Chen RL Young GD Longmore AS Shaw 1995 The conserved box 1 motif of cytokine receptors is required for association with JAK kinases J Biol Chem. 270 12 6523 6530 7896787 1:CAS:528:DyaK2MXks1yju7c%3D Tanner JW, Chen W, Young RL, Longmore GD, Shaw AS. The conserved box 1 motif of cytokine receptors is required for association with JAK kinases. J Biol Chem. 1995;270(12):6523–30.
64. 64. K He X Wang J Jiang R Guan KE Bernstein PP Sayeski 2003 Janus kinase 2 determinants for growth hormone receptor association, surface assembly, and signaling Mol Endocrinol. 17 11 2211 2227 12920237 1:CAS:528:DC%2BD3sXoslKgur4%3D He K, Wang X, Jiang J, Guan R, Bernstein KE, Sayeski PP, et al. Janus kinase 2 determinants for growth hormone receptor association, surface assembly, and signaling. Mol Endocrinol. 2003;17(11):2211–27.
65. 65. LH Hansen X Wang JJ Kopchick P Bouchelouche JH Nielsen ED Galsgaard 1996 Identification of tyrosine residues in the intracellular domain of the growth hormone receptor required for transcriptional signaling and Stat5 activation J Biol Chem. 271 12669 12673 8647880 1:CAS:528:DyaK28XjtFantLc%3D Hansen LH, Wang X, Kopchick JJ, Bouchelouche P, Nielsen JH, Galsgaard ED, et al. Identification of tyrosine residues in the intracellular domain of the growth hormone receptor required for transcriptional signaling and Stat5 activation. J Biol Chem. 1996;271:12669–73.
66. 66. LS Smit DJ Meyer N Billestrup G Norstedt J Schwartz C Carter-Su 1996 The role of the growth hormone (GH) receptor and JAK1 and JAK2 kinases in the activation of Stats 1, 3, and 5 by GH Mol Endocrinol. 10 5 519 533 8732683 1:CAS:528:DyaK28XislyisL8%3D Smit LS, Meyer DJ, Billestrup N, Norstedt G, Schwartz J, Carter-Su C. The role of the growth hormone (GH) receptor and JAK1 and JAK2 kinases in the activation of Stats 1, 3, and 5 by GH. Mol Endocrinol. 1996;10(5):519–33.
67. 67. A Sotiropoulos S Moutoussamy F Renaudie M Clauss C Kayser F Gouilleux 1996 Differential activation of Stat3 and Stat5 by distinct regions of the growth hormone receptor Molec Endocrinol. 10 998 1009 1:CAS:528:DyaK28XkslyjsLk%3D Sotiropoulos A, Moutoussamy S, Renaudie F, Clauss M, Kayser C, Gouilleux F, et al. Differential activation of Stat3 and Stat5 by distinct regions of the growth hormone receptor. Molec Endocrinol. 1996;10:998–1009.
68. 68. X Wang CJ Darus BC Xu JJ Kopchick 1996 Identification of growth hormone receptor (GHR) tyrosine residues required for GHR phosphorylation and JAK2 and STAT5 activation Mol Endocrinol. 10 10 1249 1260 9121492 1:CAS:528:DyaK28XmtF2hu74%3D Wang X, Darus CJ, Xu BC, Kopchick JJ. Identification of growth hormone receptor (GHR) tyrosine residues required for GHR phosphorylation and JAK2 and STAT5 activation. Mol Endocrinol. 1996;10(10):1249–60.
69. 69. W Yi SO Kim J Jiang SH Park AS Kraft DJ Waxman 1996 Growth hormone receptor cytoplasmic domain differentially promotes tyrosine phosphorylation of signal transducers and activators of transcription 5b and 3 by activated JAK2 kinase Mol Endocrinol. 10 11 1425 1443 8923468 1:CAS:528:DyaK28XmvFSisrg%3D Yi W, Kim SO, Jiang J, Park SH, Kraft AS, Waxman DJ, et al. Growth hormone receptor cytoplasmic domain differentially promotes tyrosine phosphorylation of signal transducers and activators of transcription 5b and 3 by activated JAK2 kinase. Mol Endocrinol. 1996;10(11):1425–43.
70. 70. PL Bergad HM Shih HC Towle SJ Schwarzenberg SA Berry 1995 Growth hormone induction of hepatic serine protease inhibitor 2.1 transcription is mediated by a Stat5-related factor binding synergistically to two gamma-activated sites J Biol Chem. 270 42 24903 24910 7559615 1:CAS:528:DyaK2MXovFWms7Y%3D Bergad PL, Shih HM, Towle HC, Schwarzenberg SJ, Berry SA. Growth hormone induction of hepatic serine protease inhibitor 2.1 transcription is mediated by a Stat5-related factor binding synergistically to two gamma-activated sites. J Biol Chem. 1995;270(42):24903–10.
71. 71. HW Davey MJ McLachlan RJ Wilkins DJ Hilton TE Adams 1999 STAT5b mediates the GH-induced expression of SOCS-2 and SOCS-3 mRNA in the liver Mol Cell Endocrinol. 158 1–2 111 116 10630411 1:CAS:528:DyaK1MXns1ahtrs%3D Davey HW, McLachlan MJ, Wilkins RJ, Hilton DJ, Adams TE. STAT5b mediates the GH-induced expression of SOCS-2 and SOCS-3 mRNA in the liver. Mol Cell Endocrinol. 1999;158(1–2):111–6.
72. 72. HW Davey T Xie MJ McLachlan RJ Wilkins DJ Waxman DR Grattan 2001 STAT5b is required for GH-induced liver IGF-I gene expression Endocrinology. 142 9 3836 3841 11517160 1:CAS:528:DC%2BD3MXmsFSgsrs%3D Davey HW, Xie T, McLachlan MJ, Wilkins RJ, Waxman DJ, Grattan DR. STAT5b is required for GH-induced liver IGF-I gene expression. Endocrinology. 2001;142(9):3836–41.
73. 73. GB Udy RP Towers RG Snell RJ Wilkins SH Park PA Ram 1997 Requirement of STAT5b for sexual dimorphism of body growth rates and liver gene expression Proc Natl Acad Sci U S A. 94 14 7239 7244 9207075 1:CAS:528:DyaK2sXksFOgu7w%3D Udy GB, Towers RP, Snell RG, Wilkins RJ, Park SH, Ram PA, et al. Requirement of STAT5b for sexual dimorphism of body growth rates and liver gene expression. Proc Natl Acad Sci U S A. 1997;94(14):7239–44.
74. 74. GT Ooi KR Hurst MN Poy MM Rechler YR Boisclair 1998 Binding of STAT5a and STAT5b to a single element resembling a gamma-interferon-activated sequence mediates the growth hormone induction of the mouse acid-labile subunit promoter in liver cells Molecular Endocrinology. 12 675 687 9605930 1:CAS:528:DyaK1cXivVSgsrc%3D Ooi GT, Hurst KR, Poy MN, Rechler MM, Boisclair YR. Binding of STAT5a and STAT5b to a single element resembling a gamma-interferon-activated sequence mediates the growth hormone induction of the mouse acid-labile subunit promoter in liver cells. Molecular Endocrinology. 1998;12:675–87.
75. 75. J Woelfle J Billiard P Rotwein 2003 Acute control of insulin-like growth factor-I gene transcription by growth hormone through Stat5b J Biol Chem. 278 25 22696 22702 12682066 1:CAS:528:DC%2BD3sXksF2it7c%3D Woelfle J, Billiard J, Rotwein P. Acute control of insulin-like growth factor-I gene transcription by growth hormone through Stat5b. J Biol Chem. 2003;278(25):22696–702.
76. 76. C Moller A Hansson B Enberg PE Lobie G Norstedt 1992 Growth hormone (GH) induction of tyrosine phosphorylation and activation of mitogen-activated protein kinases in cells transfected with rat GH receptor cDNA J Biol Chem. 267 32 23403 23408 1385420 1:STN:280:DyaK3s%2FlsVKkuw%3D%3D Moller C, Hansson A, Enberg B, Lobie PE, Norstedt G. Growth hormone (GH) induction of tyrosine phosphorylation and activation of mitogen-activated protein kinases in cells transfected with rat GH receptor cDNA. J Biol Chem. 1992;267(32):23403–8.
77. 77. J VanderKuur G Allevato N Billestrup G Norstedt C Carter-Su 1995 Growth hormone-promoted tyrosyl phosphorylation of SHC proteins and SHC association with Grb2 J Biol Chem. 13 7587 7593 VanderKuur J, Allevato G, Billestrup N, Norstedt G, Carter-Su C. Growth hormone-promoted tyrosyl phosphorylation of SHC proteins and SHC association with Grb2. J Biol Chem. 1995;13:7587–93.
78. 78. JA Vanderkuur ER Butch SB Waters JE Pessin KL Guan C Carter-Su 1997 Signaling molecules involved in coupling growth hormone receptor to mitogen-activated protein kinase activation Endocrinology. 138 10 4301 4307 9322943 1:CAS:528:DyaK2sXmsVWmsLo%3D Vanderkuur JA, Butch ER, Waters SB, Pessin JE, Guan KL, Carter-Su C. Signaling molecules involved in coupling growth hormone receptor to mitogen-activated protein kinase activation. Endocrinology. 1997;138(10):4301–7.
79. 79. T Yamauchi K Ueki K Tobe H Tamemoto N Sekine M Wada 1997 Tyrosine phosphorylation of the EGF receptor by the kinase Jak2 is induced by growth hormone Nature. 390 6655 91 96 9363897 1:CAS:528:DyaK2sXnt1Cqsrc%3D Yamauchi T, Ueki K, Tobe K, Tamemoto H, Sekine N, Wada M, et al. Tyrosine phosphorylation of the EGF receptor by the kinase Jak2 is induced by growth hormone. Nature. 1997;390(6655):91–6.
80. 80. Y Huang SO Kim J Jiang SJ Frank 2003 Growth hormone-induced phosphorylation of epidermal growth factor (EGF) receptor in 3T3-F442A cells. Modulation of EGF-induced trafficking and signaling J Biol Chem. 278 21 18902 18913 12642595 1:CAS:528:DC%2BD3sXjvVSlu7o%3D Huang Y, Kim SO, Jiang J, Frank SJ. Growth hormone-induced phosphorylation of epidermal growth factor (EGF) receptor in 3T3-F442A cells. Modulation of EGF-induced trafficking and signaling. J Biol Chem. 2003;278(21):18902–13.
81. 81. SO Kim JC Houtman J Jiang JM Ruppert PJ Bertics SJ Frank 1999 Growth hormone-induced alteration in ErbB-2 phosphorylation status in 3T3-F442A fibroblasts J Biol Chem 274 50 36015 36024 10585492 1:CAS:528:DyaK1MXotVGmt7k%3D Kim SO, Houtman JC, Jiang J, Ruppert JM, Bertics PJ, Frank SJ. Growth hormone-induced alteration in ErbB-2 phosphorylation status in 3T3-F442A fibroblasts. J Biol Chem 1999;274(50):36015–24.
82. 82. SO Kim J Jiang W Yi GS Feng SJ Frank 1998 Involvement of the Src homology 2-containing tyrosine phosphatase SHP-2 in growth hormone signaling J Biol Chem. 273 4 2344 2354 9442080 1:CAS:528:DyaK1cXnsVKiug%3D%3D Kim SO, Jiang J, Yi W, Feng GS, Frank SJ. Involvement of the Src homology 2-containing tyrosine phosphatase SHP-2 in growth hormone signaling. J Biol Chem. 1998;273(4):2344–54.
83. 83. SO Kim K Loesch X Wang J Jiang L Mei JM Cunnick 2002 A role for Grb2-associated binder-1 in growth hormone signaling Endocrinology. 143 12 4856 4867 12446613 1:CAS:528:DC%2BD38Xpt1eltLc%3D Kim SO, Loesch K, Wang X, Jiang J, Mei L, Cunnick JM, et al. A role for Grb2-associated binder-1 in growth hormone signaling. Endocrinology. 2002;143(12):4856–67.
84. 84. L Liang J Jiang SJ Frank 2000 Insulin receptor substrate-1-mediated enhancement of growth hormone-induced mitogen-activated protein kinase activation Endocrinology. 141 9 3328 3336 10965905 1:CAS:528:DC%2BD3cXmtVertr8%3D Liang L, Jiang J, Frank SJ. Insulin receptor substrate-1-mediated enhancement of growth hormone-induced mitogen-activated protein kinase activation. Endocrinology. 2000;141(9):3328–36.
85. 85. L Liang T Zhou J Jiang JH Pierce TA Gustafson SJ Frank 1999 Insulin receptor substrate-1 enhances growth hormone-induced proliferation Endocrinology. 140 5 1972 1983 10218944 1:CAS:528:DyaK1MXislSnsL8%3D Liang L, Zhou T, Jiang J, Pierce JH, Gustafson TA, Frank SJ. Insulin receptor substrate-1 enhances growth hormone-induced proliferation. Endocrinology. 1999;140(5):1972–83.
86. 86. C Hodge J Liao M Stofega K Guan C Carter-Su J Schwartz 1998 Growth hormone stimulates phosphorylation and activation of elk-1 and expression of c-fos, egr-1, and junB through activation of extracellular signal-regulated kinases 1 and 2 J Biol Chem. 273 47 31327 31336 9813041 1:CAS:528:DyaK1cXns1ensr0%3D Hodge C, Liao J, Stofega M, Guan K, Carter-Su C, Schwartz J. Growth hormone stimulates phosphorylation and activation of elk-1 and expression of c-fos, egr-1, and junB through activation of extracellular signal-regulated kinases 1 and 2. J Biol Chem. 1998;273(47):31327–36.
87. 87. V Goffin N Binart P Touraine PA Kelly 2002 Prolactin: the new biology of an old hormone Annu Rev Physiol. 64 47 67 11826263 1:CAS:528:DC%2BD38XisFGms7k%3D Goffin V, Binart N, Touraine P, Kelly PA. Prolactin: the new biology of an old hormone. Annu Rev Physiol. 2002;64:47–67.
88. 88. H Rui 2000 Prolactin JJ Oppenheim M Feldman Cytokine Reference On-Line Academic London, UK 267 283 Rui H. Prolactin. In: Oppenheim JJ, Feldman M, editors. Cytokine Reference On-Line. London, UK: Academic; 267–83; 2000.
89. 89. CV Clevenger PA Furth SE Hankinson LA Schuler 2003 The role of prolactin in mammary carcinoma Endocr Rev. 24 1 1 27 12588805 1:CAS:528:DC%2BD3sXhslOgsb8%3D Clevenger CV, Furth PA, Hankinson SE, Schuler LA. The role of prolactin in mammary carcinoma. Endocr Rev. 2003;24(1):1–27.
90. 90. V Goffin P Touraine C Pichard S Bernichtein PA Kelly 1999 Should prolactin be reconsidered as a therapeutic target in human breast cancer? Mol Cell Endocrinol. 151 1–2 79 87 10411322 1:CAS:528:DyaK1MXivFemt7s%3D Goffin V, Touraine P, Pichard C, Bernichtein S, Kelly PA. Should prolactin be reconsidered as a therapeutic target in human breast cancer? Mol Cell Endocrinol. 1999;151(1–2):79–87.
91. 91. N Ben-Jonathan K Liby M McFarland M Zinger 2002 Prolactin as an autocrine/paracrine growth factor in human cancer Trends Endocrinol Metab. 13 6 245 250 12128285 1:CAS:528:DC%2BD38XlsVOktr8%3D Ben-Jonathan N, Liby K, McFarland M, Zinger M. Prolactin as an autocrine/paracrine growth factor in human cancer. Trends Endocrinol Metab. 2002;13(6):245–50.
92. 92. BK Vonderhaar 1999 Prolactin involvement in breast cancer Endocr Relat Cancer. 6 3 389 404 10516853 1:CAS:528:DyaK1MXmsVOmt7Y%3D Vonderhaar BK. Prolactin involvement in breast cancer. Endocr Relat Cancer. 1999;6(3):389–404.
93. 93. E Anderson JE Ferguson H Morten SM Shalet EL Robinson A Howell 1993 Serum immunoreactive and bioactive lactogenic hormones in advanced breast cancer patients treated with bromocriptine and octreotide Eur J Cancer. 29A 2 209 217 8422285 1:STN:280:DyaK3s7jsF2htg%3D%3D Anderson E, Ferguson JE, Morten H, Shalet SM, Robinson EL, Howell A. Serum immunoreactive and bioactive lactogenic hormones in advanced breast cancer patients treated with bromocriptine and octreotide. Eur J Cancer. 1993;29A(2):209–17.
94. 94. RW McMurray D Weidensaul SH Allen SE Walker 1995 Efficacy of bromocriptine in an open label therapeutic trial for systemic lupus erythematosus J Rheumatol. 22 11 2084 2091 8596149 1:CAS:528:DyaK28XotVSg McMurray RW, Weidensaul D, Allen SH, Walker SE. Efficacy of bromocriptine in an open label therapeutic trial for systemic lupus erythematosus. J Rheumatol. 1995;22(11):2084–91.
95. 95. J Bonneterre L Mauriac B Weber H Roche P Fargeot M Tubiana-Hulin 1988 Tamoxifen plus bromocriptine versus tamoxifen plus placebo in advanced breast cancer: results of a double blind multicentre clinical trial Eur J Cancer Clin Oncol. 24 12 1851 1853 3065085 1:STN:280:DyaL1M7itVylug%3D%3D Bonneterre J, Mauriac L, Weber B, Roche H, Fargeot P, Tubiana-Hulin M, et al. Tamoxifen plus bromocriptine versus tamoxifen plus placebo in advanced breast cancer: results of a double blind multicentre clinical trial. Eur J Cancer Clin Oncol. 1988;24(12):1851–3.
96. 96. SE Hankinson WC Willett DS Michaud JE Manson GA Colditz C Longcope 1999 Plasma prolactin levels and subsequent risk of breast cancer in postmenopausal women J Natl Cancer Inst. 91 7 629 634 10203283 1:STN:280:DyaK1M3hsl2ntA%3D%3D Hankinson SE, Willett WC, Michaud DS, Manson JE, Colditz GA, Longcope C, et al. Plasma prolactin levels and subsequent risk of breast cancer in postmenopausal women. J Natl Cancer Inst. 1999;91(7):629–34.
97. 97. C Reynolds KT Montone CM Powell JE Tomaszewski CV Clevenger 1997 Expression of prolactin and its receptor in human breast carcinoma Endocrinology. 138 12 5555 5560 9389544 1:CAS:528:DyaK2sXnsFOqs7k%3D Reynolds C, Montone KT, Powell CM, Tomaszewski JE, Clevenger CV. Expression of prolactin and its receptor in human breast carcinoma. Endocrinology. 1997;138(12):5555–60.
98. 98. P Touraine JF Martini B Zafrani JC Durand F Labaille C Malet 1998 Increased expression of prolactin receptor gene assessed by quantitative polymerase chain reaction in human breast tumors versus normal breast tissues J Clin Endocrinol Metab. 83 2 667 674 9467590 1:CAS:528:DyaK1cXpvFeitA%3D%3D Touraine P, Martini JF, Zafrani B, Durand JC, Labaille F, Malet C, et al. Increased expression of prolactin receptor gene assessed by quantitative polymerase chain reaction in human breast tumors versus normal breast tissues. J Clin Endocrinol Metab. 1998;83(2):667–74.
99. 99. E Ginsburg BK Vonderhaar 1995 Prolactin synthesis and secretion by human breast cancer cells Cancer Res. 55 12 2591 2595 7780973 1:CAS:528:DyaK2MXmtlWrtrw%3D Ginsburg E, Vonderhaar BK. Prolactin synthesis and secretion by human breast cancer cells. Cancer Res. 1995;55(12):2591–5.
100. 100. H Wennbo J Kindblom OG Isaksson J Tornell 1997 Transgenic mice overexpressing the prolactin gene develop dramatic enlargement of the prostate gland Endocrinology. 138 10 4410 4415 9322957 1:CAS:528:DyaK2sXmsVajs7k%3D Wennbo H, Kindblom J, Isaksson OG, Tornell J. Transgenic mice overexpressing the prolactin gene develop dramatic enlargement of the prostate gland. Endocrinology. 1997;138(10):4410–5.
101. 101. NY Chen L Holle W Li SK Peirce MT Beck WY Chen 2002 In vivo studies of the anti-tumor effects of a human prolactin antagonist, hPRL-G129R Int J Oncol. 20 4 813 818 11894130 1:CAS:528:DC%2BD38XislOqsrg%3D Chen NY, Holle L, Li W, Peirce SK, Beck MT, Chen WY. In vivo studies of the anti-tumor effects of a human prolactin antagonist, hPRL-G129R. Int J Oncol. 2002;20(4):813–8.
102. 102. C Bole-Feysot V Goffin M Edery N Binart PA Kelly 1998 Prolactin (PRL) and its receptor: actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice Endocr Rev. 19 3 225 268 9626554 1:CAS:528:DyaK1cXktVWhs7k%3D Bole-Feysot C, Goffin V, Edery M, Binart N, Kelly PA. Prolactin (PRL) and its receptor: actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice. Endocr Rev. 1998;19(3):225–68.
103. 103. GS Campbell LS Argetsinger JN Ihle PA Kelly JA Rillema C Carter-Su 1994 Activation of JAK2 tyrosine kinase by prolactin receptors in Nb2 cells and mouse mammary gland explants Proc Natl Acad Sci U S A. 91 12 5232 5236 7515493 1:CAS:528:DyaK2cXkt1Ogtbo%3D Campbell GS, Argetsinger LS, Ihle JN, Kelly PA, Rillema JA, Carter-Su C. Activation of JAK2 tyrosine kinase by prolactin receptors in Nb2 cells and mouse mammary gland explants. Proc Natl Acad Sci U S A. 1994;91(12):5232–6.
104. 104. H Rui RA Kirken WL Farrar 1994 Activation of receptor-associated tyrosine kinase JAK2 by prolactin J Biol Chem. 269 7 5364 5368 7508935 1:CAS:528:DyaK2cXhvVentro%3D Rui H, Kirken RA, Farrar WL. Activation of receptor-associated tyrosine kinase JAK2 by prolactin. J Biol Chem. 1994;269(7):5364–8.
105. 105. CV Clevenger JB Kline 2001 Prolactin receptor signal transduction Lupus. 10 10 706 718 11721697 1:CAS:528:DC%2BD3MXovV2lurs%3D Clevenger CV, Kline JB. Prolactin receptor signal transduction. Lupus. 2001;10(10):706–18.
106. 106. X Liu GW Robinson KU Wagner L Garrett A Wynshaw-Boris L Hennighausen 1997 Stat5a is mandatory for adult mammary gland development and lactogenesis Genes Dev. 11 2 179 186 9009201 1:CAS:528:DyaK2sXpsVKqsg%3D%3D Liu X, Robinson GW, Wagner KU, Garrett L, Wynshaw-Boris A, Hennighausen L. Stat5a is mandatory for adult mammary gland development and lactogenesis. Genes Dev. 1997;11(2):179–86.
107. 107. N Prenzel E Zwick H Daub M Leserer R Abraham C Wallasch 1999 EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF Nature. 402 6764 884 888 10622253 1:CAS:528:DC%2BD3cXitFSltQ%3D%3D Prenzel N, Zwick E, Daub H, Leserer M, Abraham R, Wallasch C, et al. EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF. Nature. 1999;402(6764):884–8.
108. 108. S Eguchi PJ Dempsey GD Frank ED Motley T Inagami 2001 Activation of MAPKs by angiotensin II in vascular smooth muscle cells. Metalloprotease-dependent EGF receptor activation is required for activation of ERK and p38 MAPK but not for JNK J Biol Chem. 276 11 7957 7962 11116149 1:CAS:528:DC%2BD3MXitFKhu7s%3D Eguchi S, Dempsey PJ, Frank GD, Motley ED, Inagami T. Activation of MAPKs by angiotensin II in vascular smooth muscle cells. Metalloprotease-dependent EGF receptor activation is required for activation of ERK and p38 MAPK but not for JNK. J Biol Chem. 2001;276(11):7957–62.
109. 109. KL Pierce A Tohgo S Ahn ME Field LM Luttrell RJ Lefkowitz 2001 Epidermal growth factor (EGF) receptor-dependent ERK activation by G protein-coupled receptors: a co-culture system for identifying intermediates upstream and downstream of heparin-binding EGF shedding J Biol Chem. 276 25 23155 23160 11290747 1:CAS:528:DC%2BD3MXkvValsr0%3D Pierce KL, Tohgo A, Ahn S, Field ME, Luttrell LM, Lefkowitz RJ. Epidermal growth factor (EGF) receptor-dependent ERK activation by G protein-coupled receptors: a co-culture system for identifying intermediates upstream and downstream of heparin-binding EGF shedding. J Biol Chem. 2001;276(25):23155–60.
110. 110. DF McCole SJ Keely RJ Coffey KE Barrett 2002 Transactivation of the epidermal growth factor receptor in colonic epithelial cells by carbachol requires extracellular release of transforming growth factor-alpha J Biol Chem. 277 45 42603 42612 12202486 1:CAS:528:DC%2BD38Xos1ensbo%3D McCole DF, Keely SJ, Coffey RJ, Barrett KE. Transactivation of the epidermal growth factor receptor in colonic epithelial cells by carbachol requires extracellular release of transforming growth factor-alpha. J Biol Chem. 2002;277(45):42603–12.
111. 111. A Gschwind S Hart OM Fischer A Ullrich 2003 TACE cleavage of proamphiregulin regulates GPCR-induced proliferation and motility of cancer cells EMBO J 22 10 2411 2421 12743035 1:CAS:528:DC%2BD3sXjvV2gsLo%3D Gschwind A, Hart S, Fischer OM, Ullrich A. TACE cleavage of proamphiregulin regulates GPCR-induced proliferation and motility of cancer cells. EMBO J 2003;22(10):2411–21.
112. 112. J Buteau S Foisy E Joly M Prentki 2003 Glucagon-like peptide 1 induces pancreatic beta-cell proliferation via transactivation of the epidermal growth factor receptor Diabetes. 52 1 124 132 12502502 1:CAS:528:DC%2BD3sXisVaitw%3D%3D Buteau J, Foisy S, Joly E, Prentki M. Glucagon-like peptide 1 induces pancreatic beta-cell proliferation via transactivation of the epidermal growth factor receptor. Diabetes. 2003;52(1):124–32.
113. 113. RJ Epstein BJ Druker TM Roberts CD Stiles 1990 Modulation of a Mr 175,000 c-neu receptor isoform in G8/DHFR cells by serum starvation J Biol Chem. 265 18 10746 10751 1972380 1:CAS:528:DyaK3cXksFKlt7g%3D Epstein RJ, Druker BJ, Roberts TM, Stiles CD. Modulation of a Mr 175,000 c-neu receptor isoform in G8/DHFR cells by serum starvation. J Biol Chem. 1990;265(18):10746–51.
114. 114. RL Feinmesser K Gray AR Means A Chantry 1996 HER-2/c-erbB2 is phosphorylated by calmodulin-dependent protein kinase II on a single site in the cytoplasmic tail at threonine-1172 Oncogene. 12 12 2725 2730 8700533 1:CAS:528:DyaK28XktlKltbw%3D Feinmesser RL, Gray K, Means AR, Chantry A. HER-2/c-erbB2 is phosphorylated by calmodulin-dependent protein kinase II on a single site in the cytoplasmic tail at threonine-1172. Oncogene. 1996;12(12):2725–30.
115. 115. T Hunter N Ling JA Cooper 1984 Protein kinase C phosphorylation of the EGF receptor at a threonine residue close to the cytoplasmic face of the plasma membrane Nature. 311 5985 480 483 6090944 1:CAS:528:DyaL2cXlvVKqsLg%3D Hunter T, Ling N, Cooper JA. Protein kinase C phosphorylation of the EGF receptor at a threonine residue close to the cytoplasmic face of the plasma membrane. Nature. 1984;311(5985):480–3.
116. 116. GJ Heisermann GN Gill 1988 Epidermal growth factor receptor threonine and serine residues phosphorylated in vivo J Biol Chem. 263 26 13152 13158 3138233 1:CAS:528:DyaL1cXls1Kjsr0%3D Heisermann GJ, Gill GN. Epidermal growth factor receptor threonine and serine residues phosphorylated in vivo. J Biol Chem. 1988;263(26):13152–8.
117. 117. RJ Davis MP Czech 1985 Tumor-promoting phorbol diesters cause the phosphorylation of epidermal growth factor receptors in normal human fibroblasts at threonine-654 Proc Natl Acad Sci U S A. 82 7 1974 1978 2984676 1:CAS:528:DyaL2MXktVWru7w%3D Davis RJ, Czech MP. Tumor-promoting phorbol diesters cause the phosphorylation of epidermal growth factor receptors in normal human fibroblasts at threonine-654. Proc Natl Acad Sci U S A. 1985;82(7):1974–8.
118. 118. K Takishima B Friedman H Fujiki MR Rosner 1988 Thapsigargin, a novel promoter, phosphorylates the epidermal growth factor receptor at threonine 669 Biochem Biophys Res Commun. 157 2 740 746 3202876 1:CAS:528:DyaL1MXlt1OmtA%3D%3D Takishima K, Friedman B, Fujiki H, Rosner MR. Thapsigargin, a novel promoter, phosphorylates the epidermal growth factor receptor at threonine 669. Biochem Biophys Res Commun. 1988;157(2):740–6.
119. 119. K Takishima I Griswold-Prenner T Ingebritsen MR Rosner 1991 Epidermal growth factor (EGF) receptor T669 peptide kinase from 3T3-L1 cells is an EGF-stimulated “MAP” kinase Proc Natl Acad Sci U S A. 88 6 2520 2524 1848706 1:CAS:528:DyaK3MXisVehtrk%3D Takishima K, Griswold-Prenner I, Ingebritsen T, Rosner MR. Epidermal growth factor (EGF) receptor T669 peptide kinase from 3T3-L1 cells is an EGF-stimulated “MAP” kinase. Proc Natl Acad Sci U S A. 1991;88(6):2520–4.
120. 120. IC Northwood FA Gonzalez M Wartmann DL Raden RJ Davis 1991 Isolation and characterization of two growth factor-stimulated protein kinases that phosphorylate the epidermal growth factor receptor at threonine 669 J Biol Chem. 266 23 15266 15276 1651322 1:CAS:528:DyaK38Xjs1Kmsg%3D%3D Northwood IC, Gonzalez FA, Wartmann M, Raden DL, Davis RJ. Isolation and characterization of two growth factor-stimulated protein kinases that phosphorylate the epidermal growth factor receptor at threonine 669. J Biol Chem. 1991;266(23):15266–76.
121. 121. JL Countaway AC Nairn RJ Davis 1992 Mechanism of desensitization of the epidermal growth factor receptor protein-tyrosine kinase J Biol Chem. 267 2 1129 1140 1309762 1:CAS:528:DyaK38XjsFShsQ%3D%3D Countaway JL, Nairn AC, Davis RJ. Mechanism of desensitization of the epidermal growth factor receptor protein-tyrosine kinase. J Biol Chem. 1992;267(2):1129–40.
122. 122. JL Countaway P McQuilkin N Girones RJ Davis 1990 Multisite phosphorylation of the epidermal growth factor receptor. Use of site-directed mutagenesis to examine the role of serine/threonine phosphorylation J Biol Chem. 265 6 3407 3416 2105948 1:CAS:528:DyaK3cXhsFeqtL0%3D Countaway JL, McQuilkin P, Girones N, Davis RJ. Multisite phosphorylation of the epidermal growth factor receptor. Use of site-directed mutagenesis to examine the role of serine/threonine phosphorylation. J Biol Chem. 1990;265(6):3407–16.
123. 123. SJ Theroux K Stanley DA Campbell RJ Davis 1992 Mutational removal of the major site of serine phosphorylation of the epidermal growth factor receptor causes potentiation of signal transduction: role of receptor down-regulation Mol Endocrinol. 6 11 1849 1857 1480174 1:CAS:528:DyaK3sXjtlSrtw%3D%3D Theroux SJ, Stanley K, Campbell DA, Davis RJ. Mutational removal of the major site of serine phosphorylation of the epidermal growth factor receptor causes potentiation of signal transduction: role of receptor down-regulation. Mol Endocrinol. 1992;6(11):1849–57.
124. 124. J Bao I Alroy H Waterman ED Schejter C Brodie J Gruenberg 2000 Threonine phosphorylation diverts internalized epidermal growth factor receptors from a degradative pathway to the recycling endosome J Biol Chem. 275 34 26178 26186 10816576 1:CAS:528:DC%2BD3cXmt1OksLc%3D Bao J, Alroy I, Waterman H, Schejter ED, Brodie C, Gruenberg J, et al. Threonine phosphorylation diverts internalized epidermal growth factor receptors from a degradative pathway to the recycling endosome. J Biol Chem. 2000;275(34):26178–86.
125. 125. Y Huang Y Chang X Wang J Jiang SJ Frank 2004 Growth hormone alters epidermal growth factor receptor binding affinity via activation of ERKs in 3T3-F442A cells Endocrinology. 145 7 3297 3306 15070853 1:CAS:528:DC%2BD2cXltFyksb4%3D Huang Y, Chang Y, Wang X, Jiang J, Frank SJ. Growth hormone alters epidermal growth factor receptor binding affinity via activation of ERKs in 3T3-F442A cells. Endocrinology. 2004;145(7):3297–306.
126. 126. RB Pearson BE Kemp 1991 Protein kinase phosphorylation site sequences and consensus specificity motifs: tabulations Methods Enzymol. 200 62 81 1956339 1:CAS:528:DyaK38Xhs1yktLc%3D 10.1016/0076-6879(91)00127-I Pearson RB, Kemp BE. Protein kinase phosphorylation site sequences and consensus specificity motifs: tabulations. Methods Enzymol. 1991;200:62–81.
127. 127. MJ Marinissen M Chiariello JS Gutkind 2001 Regulation of gene expression by the small GTPase Rho through the ERK6 (p38 gamma) MAP kinase pathway Genes Dev. 15 5 535 553 11238375 1:CAS:528:DC%2BD3MXhvVChs78%3D Marinissen MJ, Chiariello M, Gutkind JS. Regulation of gene expression by the small GTPase Rho through the ERK6 (p38 gamma) MAP kinase pathway. Genes Dev. 2001;15(5):535–53.
128. 128. C Hall DM Nelson X Ye K Baker JA DeCaprio S Seeholzer 2001 HIRA, the human homologue of yeast Hir1p and Hir2p, is a novel cyclin-cdk2 substrate whose expression blocks S-phase progression Mol Cell Biol. 21 5 1854 1865 11238922 1:CAS:528:DC%2BD3MXhtlGhtro%3D Hall C, Nelson DM, Ye X, Baker K, DeCaprio JA, Seeholzer S, et al. HIRA, the human homologue of yeast Hir1p and Hir2p, is a novel cyclin-cdk2 substrate whose expression blocks S-phase progression. Mol Cell Biol. 2001;21(5):1854–65.
129. 129. VJ Quijano Jr. LG Sheffield 1998 Prolactin decreases epidermal growth factor receptor kinase activity via a phosphorylation-dependent mechanism J Biol Chem. 273 2 1200 1207 9422787 1:CAS:528:DyaK1cXksFygsw%3D%3D Quijano VJ Jr., Sheffield LG. Prolactin decreases epidermal growth factor receptor kinase activity via a phosphorylation-dependent mechanism. J Biol Chem. 1998;273(2):1200–7.
130. 130. JL Johnson S Fenton LG Sheffield 1996 Prolactin inhibits epidermal growth factor-induced Ras-MAPK signaling in mammary epithelial cells J Biol Chem. 271 35 21574 21578 8702944 1:CAS:528:DyaK28XlsVWqurw%3D Johnson JL, Fenton S, Sheffield LG. Prolactin inhibits epidermal growth factor-induced Ras-MAPK signaling in mammary epithelial cells. J Biol Chem. 1996;271(35):21574–8.
131. 131. SE Fenton LG Sheffield 1993 Prolactin inhibits epidermal growth factor (EGF)-stimulated signaling events in mouse mammary epithelial cells by altering EGF receptor function Mol Biol Cell. 4 8 773 780 8241565 1:CAS:528:DyaK2cXht1Gnt7s%3D Fenton SE, Sheffield LG. Prolactin inhibits epidermal growth factor (EGF)-stimulated signaling events in mouse mammary epithelial cells by altering EGF receptor function. Mol Biol Cell. 1993;4(8):773–80.
132. 132. SE Fenton LG Sheffield 1997 Prolactin inhibits EGF-induced DNA synthesis in mammary epithelium via early signaling mechanisms: possible involvement of protein kinase C Exp Cell Res. 236 1 285 293 9344609 1:CAS:528:DyaK2sXms1Gqtbk%3D Fenton SE, Sheffield LG. Prolactin inhibits EGF-induced DNA synthesis in mammary epithelium via early signaling mechanisms: possible involvement of protein kinase C. Exp Cell Res. 1997;236(1):285–93.
133. 133. MV Maus SC Reilly CV Clevenger 1999 Prolactin as a chemoattractant for human breast carcinoma Endocrinology. 140 11 5447 5450 10537179 1:CAS:528:DyaK1MXmvFemurk%3D Maus MV, Reilly SC, Clevenger CV. Prolactin as a chemoattractant for human breast carcinoma. Endocrinology. 1999;140(11):5447–50.
134. 134. S Haraguchi RA Good RW Engelman S Greene NK Day 1997 Prolactin, epidermal growth factor or transforming growth factor-alpha activate a mammary cell-specific enhancer in mouse mammary tumor virus-long terminal repeat Mol Cell Endocrinol. 129 2 145 155 9202398 1:CAS:528:DyaK2sXjvFylsr4%3D Haraguchi S, Good RA, Engelman RW, Greene S, Day NK. Prolactin, epidermal growth factor or transforming growth factor-alpha activate a mammary cell-specific enhancer in mouse mammary tumor virus-long terminal repeat. Mol Cell Endocrinol. 1997;129(2):145–55.
135. 135. Y Huang X Li J Jiang SJ Frank 2006 Prolactin modulates phosphorylation, signaling and trafficking of epidermal growth factor receptor in human T47D breast cancer cells Oncogene. 25 58 7565 7576 16785991 1:CAS:528:DC%2BD28Xht1yis7nK Huang Y, Li X, Jiang J, Frank SJ. Prolactin modulates phosphorylation, signaling and trafficking of epidermal growth factor receptor in human T47D breast cancer cells. Oncogene. 2006;25(58):7565–76.
136. 136. Li X, Huang Y, Jiang J, Frank SJ. Phosphorylation of threonine-669 of EGF receptor in response to GH and EGF: Relevance to EGF-induced receptor downregulation. Endocrine Society Program and Abstracts, 87th Annual Meeting, San Diego, CA 2005:Abstract P3–91.